Navigation Links
ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System
Date:12/10/2009

EDINA, Minn., Dec. 10 /PRNewswire/ -- ARKRAY, Inc., the world's 5th largest manufacturer of diabetes self-monitoring systems, today received FDA clearance on the new Assure Platinum Blood Glucose Monitoring System.

The Assure Platinum Blood Glucose Monitoring System is the first auto-code Assure brand blood glucose meter. Assure meters are uniquely designed for long term care and multi-resident use settings. The new Assure Platinum is feature loaded and helps facilities meet state regulatory standards and provide better resident care. Auto-coding eliminates the need for any other form of manual coding, which can reduces user error thus ensuring more consistent, accurate results.

ARKRAY's commitment to accuracy is evident in the Assure Platinum Blood Glucose Monitoring System; the new system exceeds the new heightened standards the FDA has proposed. All ARKRAY Assure Blood Glucose Monitoring Systems utilize a glucose oxidase (GO) strip chemistry, and therefore are not subject to interferences than can affect GDH-PQQ systems. The FDA believes these interferences can cause falsely high results in person with diabetes using peritoneal dialysis solutions that contain icodextrin or maltose.

Assure Blood Glucose Meters are backed by the Assure® Brilliance program - a comprehensive service program from the leaders of diabetes management in long term care. Assure Brilliance provides customer service, on-site training, QA/QC guidance, diabetes F-Tag advice for long term care, a quarterly newsletter, online continuing education programs, and more to help facilities manage complex diabetes care in their facilities.

About ARKRAY USA - ARKRAY, the leader in the Long Term Care blood glucose market, has been a pioneer for nearly 50 years in the field of automated analysis from laboratory and point-of-care systems to home use patient self-testing systems. ARKRAY is one of the few diabetes testing companies in the U.S. market today that undertakes in-house each step of the development process to bring products to market. ARKRAY strongly believes in the relentless innovation of medical technology and focused attention to producing the highest quality products. For patients and health care professionals, this means access to cutting-edge, reliable products and customer-focused service.

For more information:

www.assureusa.com or www.arkrayusa.com

SOURCE ARKRAY, Inc.


'/>"/>
SOURCE ARKRAY, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. ARKRAY, Inc. Announces Partnership With scil animal care company for the SPOTCHEM(TM) EZ Analyzer
2. ARKRAY, Inc. Receives FDA Clearance for New GLUCOCARD(R) Vital(TM) Blood Glucose Monitoring System
3. AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens
4. Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress
5. SRI International Receives National Institutes of Health Grants to Develop Improved Tomographic Imaging Technology
6. Giant Eagle(R) Pharmacy Receives Award for Operational Excellence
7. Veran Medical Receives FDA Clearance to Market Electromagnetic Navigated Bronchoscopy Product: The SPiN Drive(TM) System
8. AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa
9. HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million
10. Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing
11. Pioneer(R) Surgical Technology, Inc. Receives Prestigious Spine Technology Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Feb. 4, 2016  SciClone Pharmaceuticals, Inc. (NASDAQ: ... has entered into a settlement agreement with the ... resolving the SEC,s investigation into possible violations of ... terms of the settlement agreement, SciClone has agreed ... disgorgement, pre-judgment interest and a penalty.  This payment ...
(Date:2/4/2016)... -- Global Immunology Market to 2022 - Large ... growth Summary Immune-mediated inflammatory diseases are ... affect 5–7% of western populations. Although they are ... key patient demographics, they are pathophysiologically linked, being ... inappropriate immune response. Generally, disease-modifying anti-rheumatic drugs, a ...
(Date:2/4/2016)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... treat life-threatening diseases, today announced results for the ... 2015. --> --> ... our last quarterly call, we strategically advanced pre-clinical ... to establish the Aethlon Hemopurifier® as a leading ...
Breaking Medicine Technology:
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... life? The answer may be at the tips of your toes. Foot massage, whether ... as well as pure comfort and relaxation. The American Board of Multiple Specialties ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... franchises from across the country gathered at the La Valencia Hotel in San ... PROSHRED Chicago was named the year’s most outstanding franchise, walking away with ...
(Date:2/5/2016)... ... 05, 2016 , ... Pivot Point Consulting, a leading national ... & Services for HIT Implementation Support & Staffing report with an outstanding score ... by healthcare executives, managers and clinicians representing over 4,500 hospitals and 2,500 clinics. ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Colorize ... from on one drop zone to the next using Colorize's dynamic moving camera. Colorize ... project. This package includes a 3D slideshow environment with 1 to 5 focus points ...
(Date:2/5/2016)... ... 05, 2016 , ... Calls Blacklist has just been updated by mobile app ... the developer has fixed known bugs within the app. Calls Blacklist allows its users ... not consuming any of their device’s battery power or memory. It provides a powerful ...
Breaking Medicine News(10 mins):